Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors

J Hematother Stem Cell Res. 2002 Feb;11(1):19-32. doi: 10.1089/152581602753448513.

Abstract

Fibroblast growth factors (FGFs) belong to a family of pleiotropic heparin-binding growth factors. They exert multiple functions on various cell types of mesodermal and neuroectodermal origin, affecting cell proliferation, motility, survival, and differentiation. FGF's exert their activity by interacting with tyrosine kinase receptors (FGFRs) and cell-surface heparan sulfate proteoglycans. This article reviews recent studies on the role of the FGF/FGFR system in embryonic hematopoietic development, hematopoiesis, and hematological tumors. FGFs exert both autocrine and paracrine functions in these biological processes by acting on blood cells and their precursors and accessory cells in the bone marrow, including stromal and endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Fibroblast Growth Factors / genetics
  • Fibroblast Growth Factors / pharmacology
  • Fibroblast Growth Factors / physiology*
  • Hematologic Neoplasms / etiology
  • Hematologic Neoplasms / metabolism*
  • Hematologic Neoplasms / pathology
  • Hematopoiesis* / drug effects
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / pathology
  • Humans
  • Receptors, Fibroblast Growth Factor / genetics
  • Receptors, Fibroblast Growth Factor / metabolism
  • Receptors, Fibroblast Growth Factor / physiology*

Substances

  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factors